* Atreca Inc BCEL.OQ BCEL.O is expected to show no
change in
quarterly revenue when it reports results on March 1
(estimated).
*
* Refinitiv's mean analyst estimate for Atreca Inc is for a
loss
of 59 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Atreca Inc
is
$10, above its last closing price of $1.40.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.72 -0.73 -0.60 Beat 17.3
Jun. 30 2022 -0.70 -0.71 -0.72 Missed -1.8
Mar. 31 2022 -0.78 -0.78 -0.65 Beat 17.2
Dec. 31 2021 -0.76 -0.75 -0.79 Missed -4.6
Sep. -0.72 -0.74 -0.74 Met -0.2
30 2021
Jun. 30 2021 -0.70 -0.69 -0.72 Missed -3.7
Mar. 31 2021 -0.65 -0.65 -0.70 Missed -7.3
Dec. 31 2020 -0.63 -0.64 -0.63 Beat 1.9
This summary was machine generated February 27 at 22:25 GMT.
All figures in US dollars unless otherwise stated